Buy pharma stocks on declines: P Phani Sekhar, Angel Broking

In a chat with ET Now, P Phani Sekhar, Fund Manager-PMS, Angel Broking, shares his views on the pharma space.

ET Now: What is your call on pharma companies?

P Phani Sekhar: Things have been good for some midcap pharma companies. Although they remained midcap in their classification but revenues have almost started touching $1 billion for many of these companies, be it Lupin or Glenmark. Therefore, we have liked Glenmark for quite some time and we continue to be positive.

Apart from that, there are a host of other midcap pharma companies like Divi's Laboratories's or Strides Arcolab are good candidates. However, it would be advisable to buy them on declines.